Navigation Links
Design Resource Extends Support for Orthopaedic and Cardiovascular Devices
Date:9/26/2007

New release of the Materials for Medical Devices Database

CAMBRIDGE, England and CLEVELAND, Sept. 26 /PRNewswire/ -- ASM International and Granta Design today announced substantial enhancement to the only materials database created specifically for medical device design. The expanded resource, demonstrated at this week's Materials and Processes for Medical Devices (MPMD) Conference and Exposition in Palm Desert, CA, now helps designers of spinal implants research predicate devices and gain valuable insights in product development. The initial database module supporting cardiovascular device design has also been significantly enhanced.

The new 'Materials for Medical Devices Database: Orthopaedic Module' initially focuses on spinal implants. The module establishes records for nearly 1,200 devices for spinal interlaminal fixation orthosis, spinal intervertebral body fixation orthosis, and pedicle screw spinal systems. Records are being continuously built out to include information on device applications and constituent materials, drugs, and coatings. Each material, drug, or coating is linked to further records providing data on mechanical and engineering properties, materials producers, and specific material grades, enabling device designers to rapidly acquire information to support device design, materials screening, and various regulatory filings. Future releases will extend coverage into other orthopaedic applications.

Over 1,600 additional device records have been established in the existing 'Materials for Medical Devices Database: Cardiovascular Module', the authoritative source of mechanical, physical, biological response, and drug compatibility properties for the materials and coatings used in cardiovascular device applications. Records for key materials have been updated.

With the Materials for Medical Devices Database, device designers benefit from rapid access to authoritative sources of engineering data, biological respon
'/>"/>

SOURCE ASM International
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Designer baby for British couple
3. New !! “Designer” Gene Theray
4. Couples in Britain can have “designer” babis
5. Nanocubes Designed For Delivering Cells
6. Designer Rats Reveal Possible Heart Disease Genes
7. Designer Babies- To Create Or Not To Create!
8. Zactima Receives Fast Track Designation By The FDA
9. Dr.Tadataka Yamada Designated to open Gates for Global Health Program
10. New Test Offers Hope in Effective Hearing Aid Design for Babies
11. A Couple To Create A Designer Baby As A “Saviour Sibling

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... ,, KANSASCITY,Mo.,Nov.25/PRNewswire/--TheBa...tion,slargestmedicalcliniconDec.9-10,whenKansasCit...nsuredpeople. ,, "Thisfreecliniceventhasthepote...wodaysinsteadofjustoneandbeheldonweekdaysinsteadof...asCityFreeHealthClinicandpresidentoftheNationalAss...
(Date:11/25/2009)... ,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNew...eFDA,sCenterforDrugEvaluationandResearch,titled"AD...A,"appearsintheNov.26,2009issueofTheNewEnglandJour.../cgi-bin/prnh/20090824/FDALOGO ) ,, Inthearticl...enaccesstopainmedicationforthosewhoneeditandmanagi...
(Date:11/25/2009)... , Researchers have found evidence of a statistic...moxifen among patients whose estrogen receptor (ER...on of ER-alpha; at serine-118 (ER-alpha S118-P), a... November 25 in the Journal of the National Cance...inomas are resistant to tamoxifen. Preclinical stu...
(Date:11/25/2009)... , Evaluation and treatme... Woodstock (Vocus) November 25, 2009 ...1N1 nasal vaccines and H1N1 vaccine shots at four ...nce another shipment of vaccine has arrived. The c...stal Lake and McHenry and will be open as follows:...
(Date:11/25/2009)... ,, ARLINGTON,Va.,Nov.25/PRNewswire-USNewswi...ew"PreventHealthCareFraudActof2009,"S.2128,whichis...ilabletopreventfraudinMedicare.Thebillwasintroduce...containsseveralprovisionstheAmericanAssociationfor...whichtheAssociationproposedtoCongressinFebruary.Th...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
...fically press photographers have been suspected of...picion was unveiled// by a health official belongi...of our working hypotheses. Bird flu can be transmi... across the country,' said the health official. ...
...study conducted by India and Canada which was carr... research institute reported// a decrease in the H...15 to 24 years suffering from HIV in the states of...h Indian states. The four states account for ...
...for the elders to slip into the past and reminisce...th, but psychologists warn// that such frequent re...with the present. This phenomenon becomes a p...peating boring old yarns, it is not a normal sympt...
...ria and Tuberculosis in most developing countries ...opean Union, UNAIDS, WHO and the Indian Government...strategy against the diseases. "These diseas...he diseases in various countries," Mr.Alexander Sp...
...VT) or clot formation is on the rise among patient...r Liam Smeeth, from the London School of Hygiene a...ook at whether infection could trigger DVT or pulm...he London team found those who had suffered either...
...S. health regulators, gave their nod to the first ...tion in heart transplant patients.// The drug, ... to prevent rejection of liver and kidney transpla...ants in the U.S. each year will now have a new opt...
Other Medicine News:Health News:Reminiscing Into The Past Makes You Dissatisfied With The Present 2Health News:DVT Risk Increased After Acute Infections 2
(Date:11/25/2009)...TheFDAgrantedtraditionalapprovalforINTELENCE®...ptaseinhibitor(NNRTI).INTELENCEistheonlyNNRTIspeci...swhoareexperiencingvirologicfailurewithHIV-1strain...ts.Thetraditionalapprovalisbasedon48-weekdatafromt...urrentlymarketedintheU.S.byTibotecTherapeutics,adi...
(Date:11/25/2009)...-RegadoBiosciences,aprivatelyheldcompanyleadingthe...olagents,announcedthatDavidMazzo,PhD,CEOandPreside...thCareConferenceattheNewYorkPalaceHotelinNewYorkCi...nTuesday,December1andwillincludeanoverviewoftheCom...ram,theanticoagulantsystem,REG1.Thehealthcareindus...
(Date:11/25/2009)...rstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalprodu...ystems,announcedtodaythatClintSeverson,chairmanand...perJaffrayHealthCareConferenceonWednesday,December...YorkPalaceHotelinNewYorkCity. ,, AboutAbaxis ...ebloodanalysissystemsforuseinanyveterinaryorhumanp...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Beckman Coulter Announces Third Quarter 2009 Results 5858 1Beckman Coulter Announces Third Quarter 2009 Results 5858 2Beckman Coulter Announces Third Quarter 2009 Results 5858 3Beckman Coulter Announces Third Quarter 2009 Results 5858 4Beckman Coulter Announces Third Quarter 2009 Results 5858 5Beckman Coulter Announces Third Quarter 2009 Results 5858 6Beckman Coulter Announces Third Quarter 2009 Results 5858 7Beckman Coulter Announces Third Quarter 2009 Results 5858 8Beckman Coulter Announces Third Quarter 2009 Results 5858 9Beckman Coulter Announces Third Quarter 2009 Results 5858 10Beckman Coulter Announces Third Quarter 2009 Results 5858 11Beckman Coulter Announces Third Quarter 2009 Results 5858 12Beckman Coulter Announces Third Quarter 2009 Results 5858 13Beckman Coulter Announces Third Quarter 2009 Results 5858 14Beckman Coulter Announces Third Quarter 2009 Results 5858 15Beckman Coulter Announces Third Quarter 2009 Results 5858 16Beckman Coulter Announces Third Quarter 2009 Results 5858 17Beckman Coulter Announces Third Quarter 2009 Results 5858 18Beckman Coulter Announces Third Quarter 2009 Results 5858 19Beckman Coulter Announces Third Quarter 2009 Results 5858 20Beckman Coulter Announces Third Quarter 2009 Results 5858 21Beckman Coulter Announces Third Quarter 2009 Results 5858 22Beckman Coulter Announces Third Quarter 2009 Results 5858 23Beckman Coulter Announces Third Quarter 2009 Results 5858 24Beckman Coulter Announces Third Quarter 2009 Results 5858 25Beckman Coulter Announces Third Quarter 2009 Results 5858 26Beckman Coulter Announces Third Quarter 2009 Results 5858 27Beckman Coulter Announces Third Quarter 2009 Results 5858 28Beckman Coulter Announces Third Quarter 2009 Results 5858 29Beckman Coulter Announces Third Quarter 2009 Results 5858 30Beckman Coulter Announces Third Quarter 2009 Results 5858 31Beckman Coulter Announces Third Quarter 2009 Results 5858 32Beckman Coulter Announces Third Quarter 2009 Results 5858 33Beckman Coulter Announces Third Quarter 2009 Results 5858 34Beckman Coulter Announces Third Quarter 2009 Results 5858 35Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 1Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 2Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 3Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 4Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 5Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 6Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 7Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 8BioCryst to Present at Oppenheimer Healthcare Conference 5852 1BioCryst to Present at Oppenheimer Healthcare Conference 5852 2
...t. 18 Forest,Laboratories (NYSE: FRX ) announced...duced a significant bronchodilatory response in 17...e IIa trial presented today at the,European Respir...1) (Logo: http://www.newscom.com/cgi-bin/prnh/20...that mean FEV1 and FVC values - important,measures...
... http://www.wilsoncenter.org/globalhealth , WASHI...e W. Bush called for a reauthorization of the Pres...hich is set to expire at the end,of fiscal year 20... the,initial 2003 commitment of $15 billion to $30...20, 2007, the Woodrow Wilson Center,s Global Healt...
Other Medicine Technology:Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 2Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 3Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 4Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 5Director's Forum: PEPFAR and the Global AIDS Response 2
...the user to quickly and accurately count bacteria ...unting or manual counting. An optional 1.5X auxili...gnification to 3.0X. The adjustable focusing rod a...ed. The lens also rotates a full 360 for ready acc...
...the user to quickly and accurately count bacteria ...unting or manual counting. An optional 1.5X auxili...gnification to 3.0X. The adjustable focusing rod a...ed. The lens also rotates a full 360 for ready acc...
Accucount 2000 (115V/60Hz)
Accucount 1000 (115V/60Hz)
Medicine Products: